| Predicate |
Object |
| contentType |
Comparative Study|Journal Article|Research Support, Non-U.S. Gov't|Review |
| endingPage |
17 |
| issn |
0266-9536 |
| issueIdentifier |
4 |
| pageRange |
307-17 |
| publicationName |
Anti-cancer drug design |
| startingPage |
307 |
| bibliographicCitation |
Zunino F, Capranico G. DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des. 1990 Nov;5(4):307–17. PMID: 1963303. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_697f8a461218346c6b827c35f3630832
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b95e97af109cd61938ef31fa975d825d |
| date |
199011 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/1963303 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0266-9536
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1334 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
DNA topoisomerase II as the primary target of anti-tumor anthracyclines |
| discusses |
http://id.nlm.nih.gov/mesh/M0381050
http://id.nlm.nih.gov/mesh/M0006644
http://id.nlm.nih.gov/mesh/M0001348 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D004250Q000378
http://id.nlm.nih.gov/mesh/D004247Q000378
http://id.nlm.nih.gov/mesh/D000903Q000494 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D013329 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_5.99.1.3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 |